Ocular Therapeutix's competitors

Ocular Therapeutix's competitors include Radius Health, Assembly Biosciences, Corcept Therapeutics and Insys Therapeutics
Add company...
Ocular Therapeutix
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Radius Health
Radius is a biopharmaceutical company developing new therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases.
Assembly Biosciences
Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.
Corcept Therapeutics
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
Insys Therapeutics
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.
Founding Date
Founding Date
2006
Founding Date
2003
Founding Date
2005
Founding Date
1998
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bedford, US HQ
Locations
Waltham, US HQ
Locations
Carmel, US HQ
San Francisco, US
Locations
Menlo Park, US HQ
Locations
Chandler, US HQ
Round Rock, US
Chandler, US
Employees
Employees
118
Employees
229
Employees
69 35% increase
Employees
103
Employees
423
Valuation ($)
Valuation ($)
183.7 m
Valuation ($)
1.4 b
Valuation ($)
780.2 m
Valuation ($)
2.2 b
Valuation ($)
508.7 m
Twitter followers
Twitter followers
N/A
Twitter followers
506
Twitter followers
64
Twitter followers
87
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$140.7m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$3.6m (FY, 2017)
Cost of goods
$20.6m (FY, 2017)
Net income
Net income
($63.4m) (FY, 2017)
Net income
($254.2m) (FY, 2017)
Net income
($42.8m) (FY, 2017)
Net income
$129.1m (FY, 2017)
Net income
($228m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles